CC BY-NC-ND 4.0 · Semin Hear 2021; 42(04): 331-341
DOI: 10.1055/s-0041-1739283
Review Article

Determining Cochlear Implant Candidacy in Adults: Limitations, Expansions, and Opportunities for Improvement

Teresa A. Zwolan
1   Department of Otolaryngology – Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan
,
Gregory Basura
1   Department of Otolaryngology – Head and Neck Surgery, Michigan Medicine, Ann Arbor, Michigan
› Author Affiliations

Abstract

The safety, efficacy, and success of cochlear implants (CIs) are well established and have led to changes in criteria used by clinicians to determine who should receive a CI. Such changes in clinical decision-making have out-paced the slower-occurring changes that have taken place with regulatory bodies' and insurers' indications. We review the historical development of indications for CIs, including those of the U.S. Food and Drug Administration (FDA), Medicare, Medicaid, and private insurers. We report on expansion to include patients with greater residual hearing, such as those who receive Hybrid and EAS devices, and report on recent FDA approvals that place less emphasis on the patient's best-aided condition and greater emphasis on the ear to be treated. This includes expansion of CIs to patients with single-side deafness and asymmetric hearing loss. We review changes in the test materials used to determine candidacy, including transition from sentences in quiet to sentences in noise to the recent use of monosyllabic words and cognitive screening measures. Importantly, we discuss the recent trend to recommend CIs despite a patient not meeting FDA or insurers' indications (a practice known as “off-label”), which serves as attestation that current indications need to be updated.



Publication History

Article published online:
09 December 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Van Norman GA. Drugs, devices, and the FDA: Part 2: An overview of approval processes: FDA approval of medical devices. JACC Basic Transl Sci 2016; 1 (04) 277-287
  • 2 Fargen KM, Frei D, Fiorella D. et al. The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?. J Neurointerv Surg 2013; 5 (04) 269-275
  • 3 Roland Jr JT, Gantz BJ, Waltzman SB, Parkinson AJ. Multicenter Clinical Trial Group. United States multicenter clinical trial of the cochlear nucleus hybrid implant system. Laryngoscope 2016; 126 (01) 175-181
  • 4 Pillsbury III HC, Dillon MT, Buchman CA. et al. Multicenter US clinical trial with an electric-acoustic stimulation (EAS) system in adults: final outcomes. Otol Neurotol 2018; 39 (03) 299-305
  • 5 Gifford RH, Dorman MF, Shallop JK, Sydlowski SA. Evidence for the expansion of adult cochlear implant candidacy. Ear Hear 2010; 31 (02) 186-194
  • 6 Hinder D, Linder TE, Schlegel-Wagner C, Candreia C. Benefit of bimodal stimulation with cochlear implant and hearing aid in elderly patients. [in German] Laryngorhinootologie 2017; 96 (07) 456-460
  • 7 Devocht EMJ, Janssen AML, Chalupper J, Stokroos RJ, Kingma H, George ELJ. Self-assessment of unilateral and bimodal cochlear implant experiences in daily life. PLoS One 2020; 15 (12) e0242871
  • 8 Mancini P, Dincer D'Alessandro H, Portanova G. et al. Bimodal cochlear implantation in elderly patients. Int J Audiol 2021; 60 (06) 469-478
  • 9 Gifford R, Navarro C, Macy P, Blair L. FDA candidacy for cochlear implantation. In: Gifford R. ed. Cochlear Implant Patient Assessment, Evaluation of Candidacy, Performance and Outcomes. 2nd ed.. San Diego: Plural Publishing; 2020: 1-11
  • 10 U.S. Food and Drug Administration Information Sheet: “Off-Label” and Investigational Use of Marketed Drugs, Biologics, and Medical Devices. Guidance for Institutional Review Boards and Clinical Investigators. Content current as of May 5, 2020. Accessed July 21, 2021 at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/label-and-investigational-use-marketed-drugs-biologics-and-medical-devices
  • 11 Carlson ML, Sladen DP, Gurgel RK, Tombers NM, Lohse CM, Driscoll CL. Survey of the American Neurotology Society on Cochlear Implantation: Part 1, Candidacy assessment and expanding indications. Otol Neurotol 2018; 39 (01) e12-e19
  • 12 Chambers JD, May KE, Neumann PJ. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain. Health Aff (Millwood) 2013; 32 (06) 1109-1115
  • 13 CMS.gov. Decision Memo for Cochlear Implantation (CAG-00107N). Accessed July 21, 2021 at: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=134#:~:text=Cochlear%20implants%20were%20first%20covered,%2C%20dated%20June%2030%2C%201986
  • 14 U.S. Department of Health & Human Services, National Institutes of Health, NIH Consensus Development Program Archive. Cochlear Implants in Adults and Children. Consensus Development Conference Statement. May 15–17, 1995. Accessed July 21, 2021 at: https://consensus.nih.gov/1995/1995cochlearimplants100html.htm
  • 15 Zwolan TA, Kallogjeri D, Firszt JB, Buchman CA. Assessment of cochlear implants for adult Medicare beneficiaries aged 65 years or older who meet expanded indications of open-set sentence recognition: a multicenter nonrandomized clinical trial. JAMA Otolaryngol Head Neck Surg 2020; 146 (10) 933-941
  • 16 Sorkin D, Thomas MA. Cochlear Implantation: Health insurance and other possible ways of gaining Coverage. American Cochlear Implant Alliance (ACIA). Accessed July 21, 2021 at: https://www.acialliance.org/page/HealthIns
  • 17 Sorkin DL. Impact of Medicaid on cochlear implant access. Otol Neurotol 2019; 40 (03) e336-e341
  • 18 Fifer RC, Stach BA, Jerger JF. Evaluation of the minimal auditory capabilities (MAC) test in prelingual and postlingual hearing-impaired adults. Ear Hear 1984; 5 (02) 87-90
  • 19 Owens E, Kessler DK, Raggio MW, Schubert ED. Analysis and revision of the minimal auditory capabilities (MAC) battery. Ear Hear 1985; 6 (06) 280-290
  • 20 Auditec, Inc.. Minimal Auditory Capabilities (MAC) September 22, 2015. Accessed July 21, 2021 at: https://auditec.com/2015/09/22/minimal-auditory-capabilities-mac
  • 21 Luxford WM. Ad Hoc Subcommittee of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery. Minimum speech test battery for postlingually deafened adult cochlear implant patients. Otolaryngol Head Neck Surg 2001; 124 (02) 125-126
  • 22 Gifford R. Adult cochlear implant candidate selection. In: Gifford R. ed. Cochlear Implant Patient Assessment, Evaluation of Candidacy, Performance and Outcomes. 2nd ed.. San Diego: Plural Publishing; 2020: 13-36
  • 23 Peterson GE, Lehiste I. Revised CNC lists for auditory tests. J Speech Hear Disord 1962; 27: 62-70
  • 24 Nilsson M, Soli SD, Sullivan JA. Development of the Hearing in Noise Test for the measurement of speech reception thresholds in quiet and in noise. J Acoust Soc Am 1994; 95 (02) 1085-1099
  • 25 Spahr AJ, Dorman MF, Litvak LM. et al. Development and validation of the AzBio sentence lists. Ear Hear 2012; 33 (01) 112-117
  • 26 Etymotic, Inc.. BKB-SIN TM Speech-in-Noise Test. Accessed July 21, 2021 at: www.auditorypotential.com/MSTBfiles/MSTBManual2011-06-20%20.pdf
  • 27 Prentiss S, Snapp H, Zwolan T. Audiology practices in the preoperative evaluation and management of adult cochlear implant candidates. JAMA Otolaryngol Head Neck Surg 2020; 146 (02) 136-142
  • 28 Gifford RH, Shallop JK, Peterson AM. Speech recognition materials and ceiling effects: considerations for cochlear implant programs. Audiol Neurotol 2008; 13 (03) 193-205
  • 29 Moberly AC, Castellanos I, Mattingly JK. Neurocognitive factors contributing to cochlear implant candidacy. Otol Neurotol 2018; 39 (10) e1010-e1018
  • 30 Sladen DP, Gifford RH, Haynes D. et al. Evaluation of a revised indication for determining adult cochlear implant candidacy. Laryngoscope 2017; 127 (10) 2368-2374
  • 31 Wick CC, Kallogjeri D, McJunkin JL. et al; CI532 Study Group. Hearing and quality-of-life outcomes after cochlear implantation in adult hearing aid users 65 years or older: a secondary analysis of a nonrandomized clinical trial. JAMA Otolaryngol Head Neck Surg 2020; 146 (10) 925-932
  • 32 Perkins E, Dietrich MS, Manzoor N. et al. Further evidence for the expansion of adult cochlear implant candidacy criteria. Otol Neurotol 2021; 42 (06) 815-823
  • 33 Amoodi HA, Mick PT, Shipp DV. et al. Results with cochlear implantation in adults with speech recognition scores exceeding current criteria. Otol Neurotol 2012; 33 (01) 6-12
  • 34 Birman CS, Sanli H. Cochlear implant outcomes in patients with severe compared with profound hearing loss. Otol Neurotol 2020; 41 (04) e458-e463
  • 35 Dowell RC. The case for earlier cochlear implantation in postlingually deaf adults. Int J Audiol 2016; 55 (Suppl. 02) S51-S56
  • 36 Vickers D, Kitterick P, Verschuur C. et al. Issues in cochlear implant candidacy. Cochlear Implants Int 2016; 17 (Suppl. 01) 1-2
  • 37 Varadarajan VV, Sydlowski SA, Li MM, Anne S, Adunka OF. Evolving criteria for adult and pediatric cochlear implantation. Ear Nose Throat J 2021; 100 (01) 31-37
  • 38 Sorkin DL, Buchman CA. Cochlear implant access in six developed countries. Otol Neurotol 2016; 37 (02) e161-e164
  • 39 Shen J, Anderson MC, Arehart KH, Souza PE. Using cognitive screening tests in audiology. Am J Audiol 2016; 25 (04) 319-331
  • 40 Fakurnejad S, Vail D, Song Y, Alyono J, Blevins NH. Trends in age of cochlear implant recipients, and the impact on perioperative complication rates. Otol Neurotol 2020; 41 (04) 438-443
  • 41 Cosetti MK, Pinkston JB, Flores JM. et al. Neurocognitive testing and cochlear implantation: insights into performance in older adults. Clin Interv Aging 2016; 11: 603-613
  • 42 Uchida Y, Sugiura S, Nishita Y, Saji N, Sone M, Ueda H. Age-related hearing loss and cognitive decline - the potential mechanisms linking the two. Auris Nasus Larynx 2019; 46 (01) 1-9
  • 43 Beck D, Weinstein BE, Harvey M. Issues in cognitive screenings by audiologists. Hearing Review; January 21, 2016
  • 44 Souza P. The Importance of Cognitive Assessment in Audiology Practice. AudiologyOnline, February 11, 2019. Accessed July 21, 2021 at: https://www.audiologyonline.com/articles/20q-importance-cognitive-assessment-in-24433
  • 45 Holden LK, Finley CC, Firszt JB. et al. Factors affecting open-set word recognition in adults with cochlear implants. Ear Hear 2013; 34 (03) 342-360
  • 46 Leung J, Wang NY, Yeagle JD. et al. Predictive models for cochlear implantation in elderly candidates. Arch Otolaryngol Head Neck Surg 2005; 131 (12) 1049-1054
  • 47 Rubinstein JT, Parkinson WS, Tyler RS, Gantz BJ. Residual speech recognition and cochlear implant performance: effects of implantation criteria. Am J Otol 1999; 20 (04) 445-452